In addition, it should be pointed out that the association of LAT1 expression levels with the OS and the PFS in our patients can add further value to LAT1 as a RCC biomarker because identification of a clinically valuable prognostic marker has been needed for RCC. This evidence concerns the gene LAT and renal cell carcinoma.